169 related articles for article (PubMed ID: 35614973)
1. Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones.
Sutton C; Williams EQ; Homsi H; Beerepoot P; Nazari R; Han D; Ramsey AJ; Mash DC; Olson DE; Blough B; Salahpour A
Front Cell Neurosci; 2022; 16():832536. PubMed ID: 35614973
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Beerepoot P; Lam VM; Salahpour A
J Biol Chem; 2016 Oct; 291(42):22053-22062. PubMed ID: 27555326
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
Ng J; Zhen J; Meyer E; Erreger K; Li Y; Kakar N; Ahmad J; Thiele H; Kubisch C; Rider NL; Morton DH; Strauss KA; Puffenberger EG; D'Agnano D; Anikster Y; Carducci C; Hyland K; Rotstein M; Leuzzi V; Borck G; Reith ME; Kurian MA
Brain; 2014 Apr; 137(Pt 4):1107-19. PubMed ID: 24613933
[TBL] [Abstract][Full Text] [Related]
4. Functional Rescue of a Misfolded
Kasture A; El-Kasaby A; Szöllősi D; Asjad HMM; Grimm A; Stockner T; Hummel T; Freissmuth M; Sucic S
J Biol Chem; 2016 Sep; 291(40):20876-20890. PubMed ID: 27481941
[TBL] [Abstract][Full Text] [Related]
5. Pharmacochaperoning in a
Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
[TBL] [Abstract][Full Text] [Related]
6. Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches.
Ng J; Barral S; Waddington SN; Kurian MA
Cells; 2023 Jun; 12(13):. PubMed ID: 37443770
[TBL] [Abstract][Full Text] [Related]
7. When transporters fail to be transported: how to rescue folding-deficient SLC6 transporters.
Sucic S; Kasture A; Mazhar Asjad HM; Kern C; El-Kasaby A; Freissmuth M
J Neurol Neuromedicine; 2016 Dec; 1(9):34-40. PubMed ID: 28405636
[TBL] [Abstract][Full Text] [Related]
8. Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters.
Bhat S; Guthrie DA; Kasture A; El-Kasaby A; Cao J; Bonifazi A; Ku T; Giancola JB; Hummel T; Freissmuth M; Newman AH
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):503-516. PubMed ID: 33860180
[TBL] [Abstract][Full Text] [Related]
9. SLC6 Transporter Folding Diseases and Pharmacochaperoning.
Freissmuth M; Stockner T; Sucic S
Handb Exp Pharmacol; 2018; 245():249-270. PubMed ID: 29086036
[TBL] [Abstract][Full Text] [Related]
10. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
Elife; 2021 May; 10():. PubMed ID: 34002696
[TBL] [Abstract][Full Text] [Related]
11. A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.
Illiano P; Lanzo A; Leo D; Paglione M; Zampi G; Gainetdinov RR; Di Schiavi E
Eur J Neurosci; 2017 Jan; 45(1):207-214. PubMed ID: 27519790
[TBL] [Abstract][Full Text] [Related]
12. The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.
Farr CV; El-Kasaby A; Freissmuth M; Sucic S
Front Synaptic Neurosci; 2020; 12():588954. PubMed ID: 33192443
[TBL] [Abstract][Full Text] [Related]
13. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.
Kurian MA; Zhen J; Cheng SY; Li Y; Mordekar SR; Jardine P; Morgan NV; Meyer E; Tee L; Pasha S; Wassmer E; Heales SJ; Gissen P; Reith ME; Maher ER
J Clin Invest; 2009 Jun; 119(6):1595-603. PubMed ID: 19478460
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study.
Kurian MA; Li Y; Zhen J; Meyer E; Hai N; Christen HJ; Hoffmann GF; Jardine P; von Moers A; Mordekar SR; O'Callaghan F; Wassmer E; Wraige E; Dietrich C; Lewis T; Hyland K; Heales S; Sanger T; Gissen P; Assmann BE; Reith ME; Maher ER
Lancet Neurol; 2011 Jan; 10(1):54-62. PubMed ID: 21112253
[TBL] [Abstract][Full Text] [Related]
15. Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.
Efange SM; Mash DC; Khare AB; Ouyang Q
J Med Chem; 1998 Nov; 41(23):4486-91. PubMed ID: 9804688
[TBL] [Abstract][Full Text] [Related]
16. Rescue of Misfolded Organic Cation Transporter 3 Variants.
Angenoorth TJF; Maier J; Stankovic S; Bhat S; Sucic S; Freissmuth M; Sitte HH; Yang JW
Cells; 2022 Dec; 12(1):. PubMed ID: 36611832
[TBL] [Abstract][Full Text] [Related]
17. Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.
Heidari E; Razmara E; Hosseinpour S; Tavasoli AR; Garshasbi M
Ann Hum Genet; 2020 Jul; 84(4):315-323. PubMed ID: 32077500
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome.
Illiano P; Bass CE; Fichera L; Mus L; Budygin EA; Sotnikova TD; Leo D; Espinoza S; Gainetdinov RR
Sci Rep; 2017 Apr; 7():46280. PubMed ID: 28417953
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.
Staley JK; Ouyang Q; Pablo J; Hearn WL; Flynn DD; Rothman RB; Rice KC; Mash DC
Psychopharmacology (Berl); 1996 Sep; 127(1):10-8. PubMed ID: 8880938
[TBL] [Abstract][Full Text] [Related]
20. Infantile parkinsonism-dystonia: a dopamine "transportopathy".
Blackstone C
J Clin Invest; 2009 Jun; 119(6):1455-8. PubMed ID: 19504720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
